Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue 4, 2000, Pages 603-611

  Orrhage, Kerstin ^a   Sjöstedtb, Svante ^a   Nord, Carl Erik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CEFPODOXIME PROXETIL; OLIGOFRUCTOSE; OLIGOSACCHARIDE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ARTICLE; BACTERIAL OVERGROWTH; BACTERIUM ISOLATION; BIFIDOBACTERIUM LONGUM; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; ENTEROCOCCUS; ESCHERICHIA COLI; FECES; FEMALE; HUMAN; HUMAN EXPERIMENT; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS ACIDOPHILUS; MALE; MILK; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; YEAST;

BIFIDOBACTERIUM LONGUM; CLOSTRIDIUM DIFFICILE; ESCHERICHIA COLI; LACTOBACILLUS ACIDOPHILUS;

EID: 0033794690     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/46.4.603     Document Type: Article

References (38)

1. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections
2. The relationship between an increase in β-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances
3. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections
4. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects
5. Clinical effects of bifidobacterium preparations on pediatric intractable diarrhea
6. Impact of Lactobacillus acidophilus supplements on the human oropharyngeal and intestinal microflora
7. Prophylaxis against ampicillin-induced diarrhoea with a lactobacillus preparation
8. Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhea
9. Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment
10. Oral supplementation with lactic acid-producing bacteria during intake of clindamycin
11. Effect of supplements with Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin
12. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics
13. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine
14. Short-chain fructo-oligosaccharide administration dose-dependently increases fecal bifidobacteria in healthy humans
15. The rectal mucosa-associated microflora in patients with ulcerative colitis
16. Effect of phenoxymethyl-penicillin and clindamycin on the oral, throat and faecal microflora of man
17. Enumeration of bifidobacteria in dairy products
18. Occurrence of toxin-producing Clostridium difficile in antibiotic associated diarrhea in Sweden
19. Impact of cefpodoxime proxetil and amoxycillin on the normal oral and intestinal microflora
20. Impact of cefuroxime axetil on the normal intestinal microflora
21. Impact of Lactobacillus acidophilus on the normal intestinal microflora after administration of two antimicrobial agents
22. Treatment of Clostridium difficile diarrhea and colitis
23. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions
24. Cleaning up Clostridium difficile infection
25. Bacterial interference between Clostridium difficile and normal fecal flora
26. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG
27. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG
28. Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG
29. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease
30. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
31. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons
32. Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers
33. Survival of yoghurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypohydrochloric elderly subjects
34. Safety and tolerance of Lactobacillus reuteri in healthy adult male subjects
35. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females
36. Effect of nondigestible oligosaccharides on large-bowel functions, blood lipid concentrations and glucose absorption in young healthy male subjects
37. Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats
38. Effects of dietary inulin in serum lipids in men and women with hypercholesterolemia